AU6917400A - Use of 5-ht1b/1d agonists to treat otic pain - Google Patents

Use of 5-ht1b/1d agonists to treat otic pain

Info

Publication number
AU6917400A
AU6917400A AU69174/00A AU6917400A AU6917400A AU 6917400 A AU6917400 A AU 6917400A AU 69174/00 A AU69174/00 A AU 69174/00A AU 6917400 A AU6917400 A AU 6917400A AU 6917400 A AU6917400 A AU 6917400A
Authority
AU
Australia
Prior art keywords
ht1b
agonists
otic pain
treat otic
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69174/00A
Inventor
Daniel A. Gamache
Najam A. Sharif
John M. Yanni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU6917400A publication Critical patent/AU6917400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
AU69174/00A 1999-08-31 2000-08-18 Use of 5-ht1b/1d agonists to treat otic pain Abandoned AU6917400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38735899A 1999-08-31 1999-08-31
US09/387358 1999-08-31
PCT/US2000/022764 WO2001015677A2 (en) 1999-08-31 2000-08-18 Use of 5-ht1b/1d agonists to treat otic pain

Publications (1)

Publication Number Publication Date
AU6917400A true AU6917400A (en) 2001-03-26

Family

ID=23529535

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69174/00A Abandoned AU6917400A (en) 1999-08-31 2000-08-18 Use of 5-ht1b/1d agonists to treat otic pain

Country Status (2)

Country Link
AU (1) AU6917400A (en)
WO (1) WO2001015677A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929039D0 (en) * 1999-12-08 2000-02-02 Glaxo Group Ltd Medicaments
US7217722B2 (en) * 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
AU2001253114B2 (en) 2000-04-21 2005-08-25 Pharmacia & Upjohn Company Llc Compounds for treating fibromyalgia and chronic fatigue syndrome
PE20020146A1 (en) * 2000-07-13 2002-03-31 Upjohn Co OPHTHALMIC FORMULATION INCLUDING A CYCLOOXYGENASE-2 (COX-2) INHIBITOR
IT1320176B1 (en) * 2000-12-22 2003-11-26 Nicox Sa SOLID DISPERSIONS OF NITRATED ACTIVE INGREDIENTS.
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
DE602004013420T2 (en) 2003-01-21 2009-06-04 Senju Pharmaceutical Co., Ltd. AQUEOUS LIQUID PREPARATION WITH 2-AMINO-3- (4-BROMOBENZOYL) PHENYL ACETIC ACID
EA200800950A1 (en) * 2005-09-26 2008-08-29 ПЬЕДМОН ФАРМАСЬЮТИКАЛЗ ЭлЭлСи METHODS OF TREATMENT AND PREVENTION OF AVERAGE OTITIS WITH THE APPLICATION OF IRON-SURFACE-ACTIVE SUBSTANCES TO FACILITATE TRANSMEMBRANE INTRODUCTION OF MEDICINAL EARS
WO2007041506A1 (en) * 2005-10-03 2007-04-12 Melior Discovery, Inc. Purine formulations and methods for managing disorders
US8299295B2 (en) 2009-10-15 2012-10-30 Johnson Matthey Public Limited Company Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs
WO2017122161A1 (en) * 2016-01-15 2017-07-20 Cadila Healthcare Limited An intranasal composition comprising 5ht1b/1d receptor agonists
CA3187020A1 (en) 2020-06-12 2021-12-16 Beckley Psytech Limited Composition comprising a benzoate salt of 5-methoxy-n,n-dimethyltryptamine
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
FR2749846B1 (en) * 1996-06-17 1998-09-11 Pf Medicament METHANESULFONATE SALT OF ARYLPIPERAZINE DERIVED FROM TRYPTAMINE AND ITS SOLVATES FOR PHARMACEUTICAL USE

Also Published As

Publication number Publication date
WO2001015677A2 (en) 2001-03-08
WO2001015677A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU7062400A (en) Topical use of kappa opioid agonists to treat otic pain
AU7906100A (en) Use of retigabin for treating neuropathic pain
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001241474A1 (en) Biosensor compositions and methods of use
AU4193700A (en) Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU2001272852A1 (en) Composition for the treatment of migraine
AUPQ877300A0 (en) Topical treatment of skin
AU6917400A (en) Use of 5-ht1b/1d agonists to treat otic pain
AU2001265839A1 (en) Use of potassium channel agonists for the treatment of cancer
AU3784999A (en) Methods for treatment of pain
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2512501A (en) Use of trimebutine for treating pain
AU3896900A (en) Treatment of pain
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU5056099A (en) Compounds for use in the treatment of inflammation
AU7106300A (en) Treatment of skin disorders
AU2962200A (en) Use of agonists or antagonists of mip-3a in therapy
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU3760900A (en) Treatment of menstrual function
AU2434297A (en) The use of 5-ht1b/1d agonists to treat ocular pain
AU2002212489A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase